Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Analysts Growing Bullish on AMD; AMUU May Be Worth a Trade

BY | ETF Database
7:26 am ET 07/27/26 | 6 VIEWS
Shares of semiconductor giant Advanced Micro Devices (AMD) have more than doubled this year. The stock, one of the bellwethers in the artificial intelligence (AI) semiconductor space, traded higher last week following the company’s Advance AI event.While that event is in the rearview mirror, it confirmed that agile traders may have plenty of opportunity to make use of the Direxion Daily AMD Bull 2X Shares (AMUU ) during the back half of 2026. AMUU is designed to deliver 200% of the daily returns of the semiconductor stock. The leveraged Direxion ETF may be one for aggressive traders to monitor into year-end because the sell-side is increasingly constructive on AMD following the Advance AI event. The stock hovered around $523 late on Friday, July 24, well below the price targets set by some analysts. Following the event, Roth Capital lifted its price target on AMD to $650. Meanwhile, UBS boosted its price objective on the chip stock to $730. Split the difference and call it $690, and AMD and AMUU could offer significant upside potential going forward. On the extremely bullish side of the ledger, Baird placed a $1,250 price target on AMD, citing the AI muscle flexed by the company at the Advance AI confab. That implies the stock can more than double from current levels. If that outlook is anywhere close to accurate, AMUU could be a rewarding play for short-term traders at various points in the coming months.Catalysts Abound for AMD, AMUUDrilling down on some takeaways from the Advance AI event, solid fundamentals support AMD’s upside potential, and thus that of the geared AMUU. “The highlight for us was AMD boosting its server CPU TAM to $220 billion, which is comparable to the $200 billion TAM provided by Nvidia in recent weeks. This is up from AMD’s March forecast of $120 billion and our prior estimates for the AI market,” noted Morningstar analyst Brian Colello. For traders considering AMUU, another potential positive is the lack of evidence of material lethargy when it comes to demand for AI compute. “We’re also pleased, but less stunned, that AMD lifted its 2030 AI TAM for the entire AI accelerator market (including GPUs and related memory, CPUs, and networking) to $1.4 trillion, up from $1.0 trillion announced in November. In short, there’s no slowdown in AI compute demand,” added Colello.For more news, information, and analysis, visit the Leveraged & Inverse Content Hub.

More Commentary

Thornburg's THOR Skips the Valuation Rally
BY | ETF Database
6:32 am ET 07/27/26 | 10 VIEWS
As Small-Caps Rise, Pair These ETFs for Value, Growth Views
BY | ETF Database
8:25 am ET 07/27/26 | 2 VIEWS
As Insurers Eye Private Credit, PCR Offers a Timely Opportunity
BY | ETF Database
7:18 am ET 07/27/26 | 6 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.